Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-04

FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approves Advagen Pharma Ltd's original application for a generic carbidopa/levodopa product indicated for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

ORIG AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)